The trial passed 2a and they are moving in to the next phase
- Forums
- ASX - By Stock
- AVR
- Ann: Admedus Releases Results of HSV-2 Phase IIa Study
AVR
anteris technologies global corp.
Add to My Watchlist
5.79%
!
$4.88

Ann: Admedus Releases Results of HSV-2 Phase IIa Study, page-4
-
- There are more pages in this discussion • 111 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$4.88 |
Change
-0.300(5.79%) |
Mkt cap ! $75.66M |
Open | High | Low | Value | Volume |
$5.15 | $5.15 | $4.88 | $40.78K | 8.117K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 202 | $4.90 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.09 | 5116 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 202 | 4.900 |
1 | 1919 | 4.890 |
1 | 1169 | 4.880 |
1 | 209 | 4.780 |
1 | 1000 | 4.750 |
Price($) | Vol. | No. |
---|---|---|
5.090 | 5116 | 3 |
5.100 | 500 | 1 |
5.120 | 1880 | 1 |
5.150 | 4449 | 1 |
5.190 | 2066 | 1 |
Last trade - 10.19am 21/07/2025 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |